Found: 145
Select item for more details and to access through your institution.
Real-world treatment trends and triple class exposed status in newly diagnosed multiple myeloma patients in Japan: A retrospective claims database study.
- Published in:
- PLoS ONE, 2024, v. 19, n. 9, p. 1, doi. 10.1371/journal.pone.0310333
- By:
- Publication type:
- Article
Quality of life and symptoms among patients with relapsed/refractory AL amyloidosis treated with ixazomib‐dexamethasone versus physician's choice.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 5, p. 720, doi. 10.1002/ajh.26866
- By:
- Publication type:
- Article
Health‐related quality of life in patients with light chain amyloidosis treated with bortezomib, cyclophosphamide, and dexamethasone ± daratumumab: Results from the ANDROMEDA study.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 6, p. 719, doi. 10.1002/ajh.26536
- By:
- Publication type:
- Article
Clinical profiles of multiple myeloma in Asia-An Asian Myeloma Network study.
- Published in:
- American Journal of Hematology, 2014, v. 89, n. 7, p. 751, doi. 10.1002/ajh.23731
- By:
- Publication type:
- Article
Exposure‐Response and Population Pharmacokinetic Analyses of a Novel Subcutaneous Formulation of Daratumumab Administered to Multiple Myeloma Patients.
- Published in:
- Journal of Clinical Pharmacology, 2021, v. 61, n. 5, p. 614, doi. 10.1002/jcph.1771
- By:
- Publication type:
- Article
Diagnosis and treatment of multiple myeloma and AL amyloidosis with focus on improvement of renal lesion.
- Published in:
- Clinical & Experimental Nephrology, 2012, v. 16, n. 5, p. 659, doi. 10.1007/s10157-012-0684-5
- By:
- Publication type:
- Article
Panobinostat PK/PD profile in combination with bortezomib and dexamethasone in patients with relapsed and relapsed/refractory multiple myeloma.
- Published in:
- European Journal of Clinical Pharmacology, 2016, v. 72, n. 2, p. 153, doi. 10.1007/s00228-015-1967-z
- By:
- Publication type:
- Article
DISTRIBUTION OF IMMUNOGLOBULIN CONTAINING CELLS IN HUMAN BONE MARROW OF PATIENTS WITH LEUKEMIA.
- Published in:
- Pathology International, 1987, v. 37, n. 2, p. 193, doi. 10.1111/j.1440-1827.1987.tb03054.x
- By:
- Publication type:
- Article
CARDIOVASCULAR LESION OF CARCINOID SYNDROME An Autopsy Case of Bronchial Carcinoid.
- Published in:
- Pathology International, 1984, v. 34, n. 1, p. 201, doi. 10.1111/j.1440-1827.1984.tb02198.x
- By:
- Publication type:
- Article
Correction: Isatuximab, carfilzomib, and dexamethasone in patients with relapsed multiple myeloma: updated results from IKEMA, a randomized Phase 3 study.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Isatuximab, carfilzomib, and dexamethasone in patients with relapsed multiple myeloma: updated results from IKEMA, a randomized Phase 3 study.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00797-8
- By:
- Publication type:
- Article
Celecoxib enhances radiosensitivity of hypoxic glioblastoma cells through endoplasmic reticulum stress.
- Published in:
- Neuro-Oncology, 2013, v. 15, n. 9, p. 1186, doi. 10.1093/neuonc/not062
- By:
- Publication type:
- Article
Isatuximab Plus Carfilzomib and Dexamethasone in East Asian Patients With Relapsed Multiple Myeloma: Updated IKEMA Subgroup Analysis.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2023, v. 23, n. 10, p. e360, doi. 10.1016/j.clml.2023.06.011
- By:
- Publication type:
- Article
Isatuximab-Pomalidomide-Dexamethasone Versus Pomalidomide-Dexamethasone in East Asian Patients With Relapsed/Refractory Multiple Myeloma: ICARIA-MM Subgroup Analysis.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 8, p. e751, doi. 10.1016/j.clml.2022.04.005
- By:
- Publication type:
- Article
Daratumumab Plus Bortezomib, Melphalan, and Prednisone Versus Bortezomib, Melphalan, and Prednisone in Transplant-Ineligible Newly Diagnosed Multiple Myeloma: Frailty Subgroup Analysis of ALCYONE.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, n. 11, p. 785, doi. 10.1016/j.clml.2021.06.005
- By:
- Publication type:
- Article
P-208: Ongoing trials investigating in-class transition (iCT) from parenteral to oral proteasome inhibitor (PI)-based treatment with ixazomib in multiple myeloma (MM).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S153, doi. 10.1016/S2152-2650(21)02335-1
- By:
- Publication type:
- Article
P-198: Isatuximab plus Carfilzomib and Dexamethasone in East Asian patients with relapsed Multiple Myeloma: IKEMA subgroup analysis.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S146, doi. 10.1016/S2152-2650(21)02325-9
- By:
- Publication type:
- Article
P-193: Elotuzumab plus pomalidomide/dexamethasone for relapsed/refractory multiple myeloma: final overall survival from the phase 2 ELOQUENT-3 trial.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S143, doi. 10.1016/S2152-2650(21)02320-X
- By:
- Publication type:
- Article
Efficacy of intensive salvage regimen (VTD-PACE and DCEP regimen) in the era of novel agents.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e273, doi. 10.1016/j.clml.2019.09.451
- By:
- Publication type:
- Article
OPTIMISMM Japanese Subgroup Analysis: Pomalidomide, Bortezomib, and Dexamethasone in Relapsed or Refractory Multiple Myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e270, doi. 10.1016/j.clml.2019.09.446
- By:
- Publication type:
- Article
Bortezomib, lenalidomide, and dexamethasone in transplant-eligible newly diagnosed multiple myeloma: A multicenter retrospective comparative analysis.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e214, doi. 10.1016/j.clml.2019.09.356
- By:
- Publication type:
- Article
Elotuzumab, Pomalidomide, and Dexamethasone for Relapsed/Refractory Multiple Myeloma: Efficacy After Additional Follow-Up of the ELOQUENT-3 Study.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e164, doi. 10.1016/j.clml.2019.09.275
- By:
- Publication type:
- Article
A Phase 3 Study of Venetoclax or Placebo in Combination with Bortezomib and Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e31, doi. 10.1016/j.clml.2019.09.046
- By:
- Publication type:
- Article
Subcutaneous (SC) Daratumumab (DARA) in Combination With Standard Multiple Myeloma (MM) Treatment Regimens: An Open-label, Multicenter Phase 2 Study (PLEIADES).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e16, doi. 10.1016/j.clml.2019.09.023
- By:
- Publication type:
- Article
Autologous Hematopoietic Cell Transplantation Versus Chemotherapy Alone for Immunoglobulin Light Chain Amyloidosis: A Retrospective Study.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, n. 7, p. 413, doi. 10.1016/j.clml.2019.02.009
- By:
- Publication type:
- Article
Autologous Hematopoietic Cell Transplantation Versus Chemotherapy Alone for Immunoglobulin Light Chain Amyloidosis: A Retrospective Study.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Abnormal Heavy/Light Chain Ratio and Matched Pair Suppression Increase Residual Disease Detection Sensitivity in Patients With Multiple Myeloma With Deep Responses.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Once Monthly Elotuzumab and Lenalidomide Plus Dexamethasone for Multiple Myeloma: A Multicenter Observation Study.
- Published in:
- Acta Haematologica, 2023, v. 146, n. 2, p. 125, doi. 10.1159/000528700
- By:
- Publication type:
- Article
Phase II, Multicenter, Single-Arm, Open-Label Study to Evaluate the Efficacy and Safety of Panobinostat in Combination with Bortezomib and Dexamethasone in Japanese Patients with Relapsed or Relapsed-and-Refractory Multiple Myeloma.
- Published in:
- Acta Haematologica, 2021, v. 144, n. 3, p. 264, doi. 10.1159/000508529
- By:
- Publication type:
- Article
CD56 for Multiple Myeloma: Lack of CD56 May Be Associated with Worse Prognosis.
- Published in:
- 2018
- By:
- Publication type:
- Editorial
Survival of Multiple Myeloma Patients Aged 65-70 Years in the Era of Novel Agents and Autologous Stem Cell Transplantation.
- Published in:
- Acta Haematologica, 2014, v. 132, n. 2, p. 211, doi. 10.1159/000357394
- By:
- Publication type:
- Article
Unusual Intracytoplasmic Crystalline Inclusions in Chronic Myelomonocytic Leukemia with Double Minute Chromosomes and MYC Amplification: A Rare Case.
- Published in:
- Acta Haematologica, 2014, v. 132, n. 1, p. 68, doi. 10.1159/000355640
- By:
- Publication type:
- Article
Clinical Implications of Abnormalities of Chromosomes 1 and 13 in Multiple Myeloma.
- Published in:
- Acta Haematologica, 2003, v. 109, n. 3, p. 129, doi. 10.1159/000069287
- By:
- Publication type:
- Article
Natural Killer Cell Frequency and Serum Cytokine Levels in Monoclonal Gammopathies: Correlation of Bone Marrow Granular Lymphocytes to Prognosis.
- Published in:
- Acta Haematologica, 1997, v. 98, n. 3, p. 150, doi. 10.1159/000203610
- By:
- Publication type:
- Article
Survival outcomes among patients with multiple myeloma in the era of novel agents: exploratory assessment using an electronic medical record database in Japan.
- Published in:
- PLoS ONE, 2023, v. 17, n. 5, p. 1, doi. 10.1371/journal.pone.0285947
- By:
- Publication type:
- Article
Induction of integrin β<sub>1</sub> expression in bone marrow cells after chemotherapy correlates with the overexpression of lung resistance protein and poor outcome in patients with multiple myeloma.
- Published in:
- American Journal of Hematology, 2008, v. 83, n. 9, p. 755, doi. 10.1002/ajh.21234
- By:
- Publication type:
- Article
IAP family protein expression correlates with poor outcome of multiple myeloma patients in association with chemotherapy‐induced overexpression of multidrug resistance genes.
- Published in:
- American Journal of Hematology, 2006, v. 81, n. 11, p. 824, doi. 10.1002/ajh.20656
- By:
- Publication type:
- Article
Expression of IAP-family proteins in adult acute mixed lineage leukemia (AMLL).
- Published in:
- American Journal of Hematology, 2005, v. 78, n. 3, p. 173, doi. 10.1002/ajh.20285
- By:
- Publication type:
- Article
N-ras and p53 gene mutations in Japanese patients with myeloproliferative disorders.
- Published in:
- American Journal of Hematology, 2002, v. 71, n. 2, p. 131, doi. 10.1002/ajh.10188
- By:
- Publication type:
- Article
Isatuximab, carfilzomib, and dexamethasone in patients with relapsed multiple myeloma: updated results from IKEMA, a randomized Phase 3 study.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00797-8
- By:
- Publication type:
- Article
Isatuximab, carfilzomib, and dexamethasone in patients with relapsed multiple myeloma: updated results from IKEMA, a randomized Phase 3 study.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00797-8
- By:
- Publication type:
- Article
The efficacy and safety of modified bortezomib‐lenalidomide‐dexamethasone in transplant‐eligible patients with newly diagnosed multiple myeloma.
- Published in:
- European Journal of Haematology, 2020, v. 104, n. 2, p. 110, doi. 10.1111/ejh.13349
- By:
- Publication type:
- Article
Hemojuvelin hemochromatosis receiving iron chelation therapy with deferasirox: improvement of liver disease activity, cardiac and hematological function.
- Published in:
- 2011
- By:
- Publication type:
- Letter
The Major DNA Repair Pathway after Both Proton and Carbon-Ion Radiation is NHEJ, but the HR Pathway is More Relevant in Carbon Ions.
- Published in:
- Radiation Research, 2015, v. 183, n. 3, p. 345, doi. 10.1667/RR13904.1
- By:
- Publication type:
- Article
Stability of DNA in Escherichla coli B/r and B<sub>S-1</sub> irradiated with Ultra-violet Light.
- Published in:
- Nature, 1966, v. 212, n. 5067, p. 1265, doi. 10.1038/2121265a0
- By:
- Publication type:
- Article
Effect of Mitomycin C on Early Phenotypic Expression in the Transformation of Diplococcus pneumoniae.
- Published in:
- Nature, 1965, v. 205, n. 4974, p. 929, doi. 10.1038/205929a0
- By:
- Publication type:
- Article
A Case of Multiple Myeloma with Nuclear Hypersegmentation after MP/VAD/VCAP-IFN Therapies with a Good Prognosis.
- Published in:
- Acta Haematologica, 1993, v. 90, n. 2, p. 102, doi. 10.1159/000204385
- By:
- Publication type:
- Article
Interleukin-6-Producing Pheochromocytoma.
- Published in:
- Acta Haematologica, 1991, v. 85, n. 4, p. 217, doi. 10.1159/000204897
- By:
- Publication type:
- Article
Isatuximab with pomalidomide-dexamethasone in relapsed/refractory multiple myeloma: post-marketing surveillance in Japan.
- Published in:
- International Journal of Hematology, 2024, v. 120, n. 2, p. 217, doi. 10.1007/s12185-024-03800-5
- By:
- Publication type:
- Article
Cytomegalovirus infection during daratumumab therapy in patients with newly diagnosed multiple myeloma.
- Published in:
- International Journal of Hematology, 2024, v. 120, n. 1, p. 91, doi. 10.1007/s12185-024-03770-8
- By:
- Publication type:
- Article